SCHEMBL10074718

SCHEMBL10074718

Cc1ccc(-c2ccc3nc4c(nc3c2)-c2ccccc2/C4=N\C#N)s1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
USP8 P40818 4/20 0.34
CTSD P07339 1/20 0.34
BACE1 P56817 1/20 0.34
MAPK8 P45983 4/20 0.33
MAPK9 P45984 4/20 0.33
MAPK10 P53779 4/20 0.33
PGR P06401 1/20 0.33
TP53 P04637 1/20 0.33
CSNK1D P48730 1/20 0.32
PIK3CG P48736 1/20 0.32
MKNK2 Q9HBH9 1/20 0.32
PIK3R1 P27986 4/20 0.32
PIK3CA P42336 4/20 0.32
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10050421 0.82 RAB9A (0.40) MAPTRAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL10075004 0.79 MAOB (0.40) MAPTRAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL10074696 0.78 PIK3R1 (0.39) MAPTRAB9ASMN1; SMN2KDM4EPIK3R1
SCHEMBL10074697 0.78 PIK3R1 (0.39) MAPTRAB9ASMN1; SMN2KDM4EPIK3R1
SCHEMBL10074701 0.76 PIK3R1 (0.52) MAPTRAB9AKDM4EALDH1A1L3MBTL1
SCHEMBL10075006 0.76 PIK3R1 (0.42) MAPTRAB9ASMN1; SMN2BACE1MAPK8
SCHEMBL10074361 0.75 KDM4E (0.48) MAPTRAB9ASMN1; SMN2KDM4EUSP8
SCHEMBL10075002 0.73 PIK3R1 (0.42) MAPTSMN1; SMN2KDM4EALDH1A1USP8
SCHEMBL10074362 0.73 USP8 (0.36) MAPTRAB9ASMN1; SMN2USP8MAPK8
SCHEMBL18267369 0.72 PGR (0.49) MAPTRAB9ASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119828-B2 Material for an organic electroluminescence device and an organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2012-02-21 US disclosed
US-20100044686-A1 MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100044686-A1 MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE AFF4, KCNH3, HCN4 MAPT 4038/4885RAB9A 2334/4885SMN1; SMN2 3923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.